BACKGROUND. Amyotrophic lateral sclerosis (ALS) is a chronic degenerative neurologic disorder characterized by the death of motor neurons in the cerebral cortex and spinal cord. Recent studies have suggested that the metabolism of glutamate, a potentially neurotoxic amino acid, is abnormal in patients with ALS. We hypothesized that the high-affinity glutamate transporter is the site of the defect. METHODS. We measured high-affinity, sodium-dependent glutamate transport in synaptosomes from neural tissue obtained from 13 patients with ALS, 17 patients with no neurologic disease, and 27 patients with other neuro-degenerative diseases (Alzheimer's disease in 15 patients and Huntington's disease in 12 patients). The groups were comparable with respect to age and the interval between death and autopsy. Synaptosomes were prepared from spinal cord, motor cortex, sensory cortex, visual cortex, striatum, and hippocampus. We also measured sodium-dependent transport of gamma-aminobutyric acid and phenylalanine in the synaptosomal preparations. RESULTS. In patients with ALS, there was a marked decrease in the maximal velocity of transport for high-affinity glutamate uptake in synaptosomes from spinal cord (-59 percent, P less than 0.001), motor cortex (-70 percent, P less than 0.001), and somatosensory cortex (-39 percent, P less than 0.05), but not in those from visual cortex, striatum, or hippocampus. The affinity of the transporter for glutamate was not altered. No abnormalities in glutamate transport were found in synaptosomes from patients with other chronic neurodegenerative disorders. The transport of gamma-aminobutyric acid and phenylalanine was normal in patients with ALS. CONCLUSIONS. ALS is associated with a defect in high-affinity glutamate transport that has disease, region, and chemical specificity. Defects in the clearance of extracellular glutamate because of a faulty transporter could lead to neurotoxic levels of extracellular glutamate and thus be pathogenic in ALS.
Source Information
Department of Neurology, Johns Hopkins University, Baltimore, MD 21205.
This article has been cited by other articles:
David, Y., Cacheaux, L. P., Ivens, S., Lapilover, E., Heinemann, U., Kaufer, D., Friedman, A.
(2009). Astrocytic Dysfunction in Epileptogenesis: Consequence of Altered Potassium and Glutamate Homeostasis?. J. Neurosci.
29: 10588-10599
[Abstract][Full Text]
Lobsiger, C. S., Boillee, S., McAlonis-Downes, M., Khan, A. M., Feltri, M. L., Yamanaka, K., Cleveland, D. W.
(2009). Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proc. Natl. Acad. Sci. USA
106: 4465-4470
[Abstract][Full Text]
Chang, Q., Martin, L. J.
(2009). Glycinergic Innervation of Motoneurons Is Deficient in Amyotrophic Lateral Sclerosis Mice: A Quantitative Confocal Analysis. Am. J. Pathol.
174: 574-585
[Abstract][Full Text]
Lee, S.-G., Su, Z.-Z., Emdad, L., Gupta, P., Sarkar, D., Borjabad, A., Volsky, D. J., Fisher, P. B.
(2008). Mechanism of Ceftriaxone Induction of Excitatory Amino Acid Transporter-2 Expression and Glutamate Uptake in Primary Human Astrocytes. J. Biol. Chem.
283: 13116-13123
[Abstract][Full Text]
Fontana, A. C. K., de Oliveira Beleboni, R., Wojewodzic, M. W., Santos, W. F. d., Coutinho-Netto, J., Grutle, N. J., Watts, S. D., Danbolt, N. C., Amara, S. G.
(2007). Enhancing Glutamate Transport: Mechanism of Action of Parawixin1, a Neuroprotective Compound from Parawixia bistriata Spider Venom. Mol. Pharmacol.
72: 1228-1237
[Abstract][Full Text]
Torres-Salazar, D., Fahlke, C.
(2007). Parawixin1: A Spider Toxin Opening New Avenues for Glutamate Transporter Pharmacology. Mol. Pharmacol.
72: 1100-1102
[Abstract][Full Text]
Regan, M. R., Huang, Y. H., Kim, Y. S., Dykes-Hoberg, M. I., Jin, L., Watkins, A. M., Bergles, D. E., Rothstein, J. D.
(2007). Variations in Promoter Activity Reveal a Differential Expression and Physiology of Glutamate Transporters by Glia in the Developing and Mature CNS. J. Neurosci.
27: 6607-6619
[Abstract][Full Text]
Tian, G., Lai, L., Guo, H., Lin, Y., Butchbach, M. E. R., Chang, Y., Lin, C.-l. G.
(2007). Translational Control of Glial Glutamate Transporter EAAT2 Expression. J. Biol. Chem.
282: 1727-1737
[Abstract][Full Text]
Augustin, H., Grosjean, Y., Chen, K., Sheng, Q., Featherstone, D. E.
(2007). Nonvesicular Release of Glutamate by Glial xCT Transporters Suppresses Glutamate Receptor Clustering In Vivo. J. Neurosci.
27: 111-123
[Abstract][Full Text]
Sharifullina, E., Nistri, A.
(2006). Glutamate uptake block triggers deadly rhythmic bursting of neonatal rat hypoglossal motoneurons. J. Physiol.
572: 407-423
[Abstract][Full Text]
Corti, S., Locatelli, F., Papadimitriou, D., Donadoni, C., Del Bo, R., Crimi, M., Bordoni, A., Fortunato, F., Strazzer, S., Menozzi, G., Salani, S., Bresolin, N., Comi, G. P.
(2006). Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1. Hum Mol Genet
15: 167-187
[Abstract][Full Text]
Li, L., Murphy, T. H., Hayden, M. R., Raymond, L. A.
(2004). Enhanced Striatal NR2B-Containing N-Methyl-D-Aspartate Receptor-Mediated Synaptic Currents in a Mouse Model of Huntington Disease. J. Neurophysiol.
92: 2738-2746
[Abstract][Full Text]
Darman, J., Backovic, S., Dike, S., Maragakis, N. J., Krishnan, C., Rothstein, J. D., Irani, D. N., Kerr, D. A.
(2004). Viral-Induced Spinal Motor Neuron Death Is Non-Cell-Autonomous and Involves Glutamate Excitotoxicity. J. Neurosci.
24: 7566-7575
[Abstract][Full Text]
Duarte, A. I., Santos, M. S., Seica, R., Oliveira, C. R.
(2004). Oxidative Stress Affects Synaptosomal {gamma}-Aminobutyric Acid and Glutamate Transport in Diabetic Rats: The Role of Insulin. Diabetes
53: 2110-2116
[Abstract][Full Text]
Mills, K. R.
(2003). The natural history of central motor abnormalities in amyotrophic lateral sclerosis. Brain
126: 2558-2566
[Abstract][Full Text]
Guo, H., Lai, L., Butchbach, M. E.R., Stockinger, M. P., Shan, X., Bishop, G. A., Lin, C.-l. G.
(2003). Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Hum Mol Genet
12: 2519-2532
[Abstract][Full Text]
Ghadge, G. D., Slusher, B. S., Bodner, A., Canto, M. D., Wozniak, K., Thomas, A. G., Rojas, C., Tsukamoto, T., Majer, P., Miller, R. J., Monti, A. L., Roos, R. P.
(2003). Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models. Proc. Natl. Acad. Sci. USA
100: 9554-9559
[Abstract][Full Text]
Rao, S. D., Yin, H. Z., Weiss, J. H.
(2003). Disruption of Glial Glutamate Transport by Reactive Oxygen Species Produced in Motor Neurons. J. Neurosci.
23: 2627-2633
[Abstract][Full Text]
Dunlop, J., Beal McIlvain, H., She, Y., Howland, D. S.
(2003). Impaired Spinal Cord Glutamate Transport Capacity and Reduced Sensitivity to Riluzole in a Transgenic Superoxide Dismutase Mutant Rat Model of Amyotrophic Lateral Sclerosis. J. Neurosci.
23: 1688-1696
[Abstract][Full Text]
Puttaparthi, K., Gitomer, W. L., Krishnan, U., Son, M., Rajendran, B., Elliott, J. L.
(2002). Disease Progression in a Transgenic Model of Familial Amyotrophic Lateral Sclerosis Is Dependent on Both Neuronal and Non-Neuronal Zinc Binding Proteins. J. Neurosci.
22: 8790-8796
[Abstract][Full Text]
Behrens, P. F., Franz, P., Woodman, B., Lindenberg, K. S., Landwehrmeyer, G. B.
(2002). Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain
125: 1908-1922
[Abstract][Full Text]
Sepkuty, J. P., Cohen, A. S., Eccles, C., Rafiq, A., Behar, K., Ganel, R., Coulter, D. A., Rothstein, J. D.
(2002). A Neuronal Glutamate Transporter Contributes to Neurotransmitter GABA Synthesis and Epilepsy. J. Neurosci.
22: 6372-6379
[Abstract][Full Text]
Sun, W., Funakoshi, H., Nakamura, T.
(2002). Overexpression of HGF Retards Disease Progression and Prolongs Life Span in a Transgenic Mouse Model of ALS. J. Neurosci.
22: 6537-6548
[Abstract][Full Text]
Martin, K. R. G., Levkovitch-Verbin, H., Valenta, D., Baumrind, L., Pease, M. E., Quigley, H. A.
(2002). Retinal Glutamate Transporter Changes in Experimental Glaucoma and after Optic Nerve Transection in The Rat. IOVS
43: 2236-2243
[Abstract][Full Text]
Yuan, C.-S., Dey, L., Xie, J.-T., Aung, H. H.
(2002). Pharmacology and toxicology of astrocyte-neuron glutamate transport and cycling.. J. Pharmacol. Exp. Ther.
301: 1-6
[Abstract][Full Text]
Howland, D. S., Liu, J., She, Y., Goad, B., Maragakis, N. J., Kim, B., Erickson, J., Kulik, J., DeVito, L., Psaltis, G., DeGennaro, L. J., Cleveland, D. W., Rothstein, J. D.
(2002). Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. USA
10.1073/pnas.032539299v1
[Abstract][Full Text]
Canton, T., Bohme, G. A., Boireau, A., Bordier, F., Mignani, S., Jimonet, P., Jahn, G., Alavijeh, M., Stygall, J., Roberts, S., Brealey, C., Vuilhorgne, M., Debono, M.-W., Le Guern, S., Laville, M., Briet, D., Roux, M., Stutzmann, J.-M., Pratt, J.
(2001). RPR 119990, a Novel alpha -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Antagonist: Synthesis, Pharmacological Properties, and Activity in an Animal Model of Amyotrophic Lateral Sclerosis. J. Pharmacol. Exp. Ther.
299: 314-322
[Abstract][Full Text]
Pramatarova, A., Laganiere, J., Roussel, J., Brisebois, K., Rouleau, G. A.
(2001). Neuron-Specific Expression of Mutant Superoxide Dismutase 1 in Transgenic Mice Does Not Lead to Motor Impairment. J. Neurosci.
21: 3369-3374
[Abstract][Full Text]
Maragakis, N. J., Rothstein, J. D.
(2001). Glutamate Transporters in Neurologic Disease. Arch Neurol
58: 365-370
[Full Text]
Ferrarese, C., Sala, G., Riva, R., Begni, B., Zoia, C., Tremolizzo, L., Galimberti, G., Millul, A., Bastone, A., Mennini, T., Balzarini, C., Frattola, L., Beghi, E.
(2001). Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology
56: 270-272
[Abstract][Full Text]
Sinor, J. D., Du, S., Venneti, S., Blitzblau, R. C., Leszkiewicz, D. N., Rosenberg, P. A., Aizenman, E.
(2000). NMDA and Glutamate Evoke Excitotoxicity at Distinct Cellular Locations in Rat Cortical Neurons In Vitro. J. Neurosci.
20: 8831-8837
[Abstract][Full Text]
Honig, L. S., Chambliss, D. D., Bigio, E. H., Carroll, S. L., Elliott, J. L.
(2000). Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls. Neurology
55: 1082-1088
[Abstract][Full Text]
Vielhaber, S., Kunz, D., Winkler, K., Wiedemann, F. R., Kirches, E., Feistner, H., Heinze, H.-J., Elger, C. E., Schubert, W., Kunz, W. S.
(2000). Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain
123: 1339-1348
[Abstract][Full Text]
Vanselow, B. K, Keller, B. U
(2000). Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneurone disease. J. Physiol.
525: 433-445
[Abstract][Full Text]
PEDERSEN, W. A., LUO, H., KRUMAN, I., KASARSKIS, E., MATTSON, M. P.
(2000). The prostate apoptosis response-4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis. FASEB J.
14: 913-924
[Abstract][Full Text]
Beghi, E., Chio, A., Inghilleri, M., Mazzini, L., Micheli, A., Mora, G., Poloni, M., Riva, R., Serlenga, L., Testa, D., Tonali, P.
(2000). A randomized controlled trial of recombinant interferon beta-1a in ALS. Neurology
54: 469-469
[Abstract][Full Text]
Gong, Y. H., Parsadanian, A. S., Andreeva, A., Snider, W. D., Elliott, J. L.
(2000). Restricted Expression of G86R Cu/Zn Superoxide Dismutase in Astrocytes Results in Astrocytosis But Does Not Cause Motoneuron Degeneration. J. Neurosci.
20: 660-665
[Abstract][Full Text]
Berger, M. M., Kopp, N., Vital, C., Redl, B., Aymard, M., Lina, B.
(2000). Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology
54: 20-20
[Abstract][Full Text]
Carriedo, S. G., Sensi, S. L., Yin, H. Z., Weiss, J. H.
(2000). AMPA Exposures Induce Mitochondrial Ca2+ Overload and ROS Generation in Spinal Motor Neurons In Vitro. J. Neurosci.
20: 240-250
[Abstract][Full Text]
Masson, J., Sagne, C., Hamon, M., Mestikawy, S. E.
(1999). Neurotransmitter Transporters in the Central Nervous System. Pharmacol. Rev.
51: 439-464
[Abstract][Full Text]
Shaw, P. J
(1999). Science, medicine, and the future: Motor neurone disease. BMJ
318: 1118-1121
[Full Text]
MEYER, T., MÜNCH, C., LIEBAU, S., FROMM, A., SCHWALENSTÖCKER, B., VÖLKEL, H., LUDOLPH, A. C
(1998). Splicing of the glutamate transporter EAAT2: a candidate gene of amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry
65: 954-954
[Full Text]
Roy, J., Minotti, S., Dong, L., Figlewicz, D. A., Durham, H. D.
(1998). Glutamate Potentiates the Toxicity of Mutant Cu/Zn-Superoxide Dismutase in Motor Neurons by Postsynaptic Calcium-Dependent Mechanisms. J. Neurosci.
18: 9673-9684
[Abstract][Full Text]
PALACIN, M., ESTEVEZ, R., BERTRAN, J., ZORZANO, A.
(1998). Molecular Biology of Mammalian Plasma Membrane Amino Acid Transporters. Physiol. Rev.
78: 969-1054
[Abstract][Full Text]
BAJAJ, N P S, IRVING, N G, LEIGH, P N, MILLER, C C J
(1998). Alzheimer's disease, amyotrophic lateral sclerosis, and transgenic mice. J. Neurol. Neurosurg. Psychiatry
64: 711-715
[Full Text]
Lange, D. J., Murphy, P. L., Diamond, B., Appel, V., Lai, E. C., Younger, D. S., Appel, S. H.
(1998). Selegiline Is Ineffective in a Collaborative Double-blind, Placebo-Controlled Trial for Treatment of Amyotrophic Lateral Sclerosis. Arch Neurol
55: 93-96
[Abstract][Full Text]
Wang, G. J., Chung, H. J., Schnuer, J., Pratt, K., Zable, A. C., Kavanaugh, M. P., Rosenberg, P. A.
(1998). High Affinity Glutamate Transport in Rat Cortical Neurons in Culture. Mol. Pharmacol.
53: 88-96
[Abstract][Full Text]
Furuta, A., Rothstein, J. D., Martin, L. J.
(1997). Glutamate Transporter Protein Subtypes Are Expressed Differentially during Rat CNS Development. J. Neurosci.
17: 8363-8375
[Abstract][Full Text]
Gegelashvili, G., Schousboe, A.
(1997). High Affinity Glutamate Transporters: Regulation of Expression and Activity. Mol. Pharmacol.
52: 6-15
[Abstract][Full Text]
Romano, J. G.
(1996). Reduction of Fasciculations in Patients With Amyotrophic Lateral Sclerosis With the Use of Gabapentin. Arch Neurol
53: 716-716
[Abstract]
Carriedo, S. G., Yin, H. Z., Weiss, J. H.
(1996). Motor Neurons Are Selectively Vulnerable to AMPA/Kainate Receptor-Mediated Injury In Vitro. J. Neurosci.
16: 4069-4079
[Abstract][Full Text]
Trotti, D., Rossi, D., Gjesdal, O., Levy, L. M., Racagni, G., Danbolt, N. C., Volterra, A.
(1996). Peroxynitrite Inhibits Glutamate Transporter Subtypes. J. Biol. Chem.
271: 5976-5979
[Abstract][Full Text]
Howard, R S
(1994). Recent Advances: Neurology. BMJ
309: 392-5
[Full Text]
Bensimon, G., Lacomblez, L., Meininger, V., The ALS/Riluzole Study Group,
(1994). A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis. NEJM
330: 585-591
[Abstract][Full Text]
Schumer, R. A., Podos, S. M.
(1994). The Nerve of Glaucoma!. Arch Ophthalmol
112: 37-44
[Abstract]
Coyle, J., Puttfarcken, P
(1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science
262: 689-695
[Abstract]
Joynt, R. J.
(1993). Neurology. JAMA
270: 228-230
[Abstract]
Wierzbicki, A.S., Engel, W. K., Smith, R. G., Stefani, E., Appel, S. H.
(1993). Antibodies to L-Type Calcium Channels in Amyotrophic Lateral Sclerosis. NEJM
328: 1355-1357
[Full Text]
Choi, D.
(1992). Bench to bedside: the glutamate connection. Science
258: 241-243
Trotti, D., Aoki, M., Pasinelli, P., Berger, U. V., Danbolt, N. C., Brown, R. H. Jr., Hediger, M. A.
(2001). Amyotrophic Lateral Sclerosis-linked Glutamate Transporter Mutant Has Impaired Glutamate Clearance Capacity. J. Biol. Chem.
276: 576-582
[Abstract][Full Text]
Howland, D. S., Liu, J., She, Y., Goad, B., Maragakis, N. J., Kim, B., Erickson, J., Kulik, J., DeVito, L., Psaltis, G., DeGennaro, L. J., Cleveland, D. W., Rothstein, J. D.
(2002). Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. USA
99: 1604-1609
[Abstract][Full Text]
Previous
